Pacific Biosciences of California Revenue Quarterly:
5.578M for Dec. 31, 2012Pacific Biosciences of California Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 5.578M |
| Dec. 31, 2012 | 5.878M |
| Sept. 30, 2012 | 2.776M |
| June 30, 2012 | 7.291M |
| March 31, 2012 | 10.04M |
| Dec. 31, 2011 | 12.44M |
| Sept. 30, 2011 | 10.52M |
| June 30, 2011 | 10.63M |
| March 31, 2011 | 0.27M |
| Dec. 31, 2010 | 0.28M |
| Sept. 30, 2010 | 0.22M |
| June 30, 2010 | 0.629M |
| March 31, 2010 | 0.545M |
| Dec. 31, 2009 | 0.135M |
| Sept. 30, 2009 | 0.00 |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
PACB Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| NPS Pharmaceuticals | 27.18M |
| Lexicon Pharmaceuticals | 0.218M |
| MannKind Corporation | 0.00 |
PACB Revenue Quarterly Rankings
| Overall |
43rd percentile 4261 of 7590 |
| Sector |
46th percentile 349 of 651 in Healthcare |
| Industry |
68th percentile 74 of 238 in Biotechnology |
PACB Revenue Quarterly Range, Past 5 Years
| Minimum | 0.00 | Sep 2009 |
| Maximum | 12.44M | Dec 2011 |
| Average | 4.482M |
